VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
92,076
AK1,880
AL6,345
AR4,151
AS46
AZ14,991
CA66,887
CO12,550
CT8,943
DC1,795
DE2,009
FL42,724
FM4
GA17,031
GU124
HI2,580
IA4,919
ID2,892
IL22,128
IN24,197
KS5,047
KY9,111
LA5,500
MA15,718
MD13,434
ME3,351
MH8
MI20,971
MN13,585
MO10,747
MP30
MS3,198
MT2,477
NC18,051
ND1,501
NE3,109
NH3,218
NJ20,216
NM4,218
NV4,728
NY37,667
OH20,793
OK6,692
OR9,244
PA25,607
PR2,588
QM2
RI2,163
SC7,261
SD1,282
TN10,445
TX39,890
UT4,618
VA15,980
VI67
VT1,830
WA16,071
WI12,042
WV2,571
WY926
XB5
XL1
XV2

ID: 1551673
Sex: F
Age: 42
State: MA

Vax Date: 02/13/2021
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Chills; Fever 102 ?F; nausea; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), PYREXIA (Fever 102 ?F) and NAUSEA (nausea) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unk) for COVID-19 vaccination. No Medical History information was reported. On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHILLS (Chills), PYREXIA (Fever 102 ?F) and NAUSEA (nausea). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, CHILLS (Chills), PYREXIA (Fever 102 ?F) and NAUSEA (nausea) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported.

Other Meds:

Current Illness:

ID: 1551674
Sex: M
Age:
State: PA

Vax Date: 02/13/2021
Onset Date: 02/16/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sore throat; it hurts when he swallows; he had a lot of pain; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), PHARYNGEAL SWELLING (it hurts when he swallows) and OROPHARYNGEAL PAIN (he had a lot of pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), PHARYNGEAL SWELLING (it hurts when he swallows) and OROPHARYNGEAL PAIN (he had a lot of pain). The patient was treated with AMOXICILLIN TRIHYDRATE, CLAVULANATE POTASSIUM (AMOXICILLIN & CLAV. POTASSIUM) ongoing from 19-Feb-2021 at a dose of UNK dosage form. At the time of the report, OROPHARYNGEAL PAIN (sore throat), PHARYNGEAL SWELLING (it hurts when he swallows) and OROPHARYNGEAL PAIN (he had a lot of pain) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported.

Other Meds:

Current Illness:

ID: 1551675
Sex: F
Age: 71
State: WI

Vax Date: 01/30/2021
Onset Date: 02/08/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Red skin scarring; Tenderness - Near Vaccination Site; Redness - NearVccination Site; Swelling - Near Vaccination Site; Hot to Touch Sensation - Near vaccination Site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot to Touch Sensation - Near vaccination Site), ERYTHEMA (Red skin scarring), TENDERNESS (Tenderness - Near Vaccination Site), VACCINATION SITE ERYTHEMA (Redness - NearVccination Site) and VACCINATION SITE SWELLING (Swelling - Near Vaccination Site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. Concurrent medical conditions included Bigeminy, Hypertension, Type II diabetes mellitus, Shellfish allergy and Drug allergy. Concomitant products included HCTZ, METFORMIN, ATORVASTATIN CALCIUM (LIPITOR) and ATENOLOL for an unknown indication. On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Hot to Touch Sensation - Near vaccination Site), TENDERNESS (Tenderness - Near Vaccination Site), VACCINATION SITE ERYTHEMA (Redness - NearVccination Site) and VACCINATION SITE SWELLING (Swelling - Near Vaccination Site). On 09-Feb-2021, the patient experienced ERYTHEMA (Red skin scarring). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) (oral) for Adverse event, at a dose of 1-2, prn and CEFALEXIN for Adverse event, at an unspecified dose and frequency. On 06-Mar-2021, VACCINATION SITE WARMTH (Hot to Touch Sensation - Near vaccination Site), ERYTHEMA (Red skin scarring), TENDERNESS (Tenderness - Near Vaccination Site), VACCINATION SITE ERYTHEMA (Redness - NearVccination Site) and VACCINATION SITE SWELLING (Swelling - Near Vaccination Site) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. This case was linked to MOD-2021-259356 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Follow up received on 14-JUL-2021 contains patient demographic information, race information, medical history, concomitant drugs information.

Other Meds: HCTZ; METFORMIN; LIPITOR; ATENOLOL

Current Illness: Bigeminy; Drug allergy; Hypertension; Shellfish allergy; Type II diabetes mellitus

ID: 1551676
Sex: F
Age: 66
State: CO

Vax Date: 02/15/2021
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: General body pain; Blurry vision; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (General body pain), NAUSEA (Nausea) and VISION BLURRED (Blurry vision) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. Concomitant products included METFORMIN for Blood pressure. On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (General body pain), NAUSEA (Nausea) and VISION BLURRED (Blurry vision). At the time of the report, PAIN (General body pain), NAUSEA (Nausea) and VISION BLURRED (Blurry vision) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.

Other Meds: METFORMIN

Current Illness:

ID: 1551677
Sex: F
Age: 68
State: IL

Vax Date: 02/19/2021
Onset Date: 02/20/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arm) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The patient's past medical history included Rheumatoid arthritis. Concomitant products included PARACETAMOL (TYLENOL) for Rheumatoid arthritis. On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm). On 21-Feb-2021, PAIN IN EXTREMITY (Pain in arm) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: TYLENOL

Current Illness:

ID: 1551678
Sex: M
Age: 77
State: MS

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tiredness; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tiredness) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. No Medical History information was reported. On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced FATIGUE (tiredness). The patient was treated with PARACETAMOL (TYLENOL) for Tiredness, at an unspecified dose and frequency. At the time of the report, FATIGUE (tiredness) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. Patient reported that he received second dose of Pfizer and experienced adverse events.

Other Meds:

Current Illness:

ID: 1551679
Sex: M
Age:
State: GA

Vax Date: 02/18/2021
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Heart rate increased; Weakness; Ache; Pain in arm; Redness; Swelling arm; Dizziness; Chills; Throat tightness; Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), HEART RATE INCREASED (Heart rate increased), HEADACHE (Headache), ASTHENIA (Weakness) and PAIN (Ache) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031LZ0A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 (Tested positive for antibodies in November 2020. Waited 90 days before receiving the vaccine. ) in October 2020. Concurrent medical conditions included Shellfish allergy. On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever), HEART RATE INCREASED (Heart rate increased), HEADACHE (Headache), ASTHENIA (Weakness), PAIN (Ache), PAIN IN EXTREMITY (Pain in arm), ERYTHEMA (Redness), PERIPHERAL SWELLING (Swelling arm), DIZZINESS (Dizziness), CHILLS (Chills) and THROAT TIGHTNESS (Throat tightness). The patient was treated with DIPHENHYDRAMINE, PARACETAMOL (EXTRA STRENGTH TYLENOL PM) at a dose of UNK dosage form. At the time of the report, PYREXIA (Fever), HEART RATE INCREASED (Heart rate increased), HEADACHE (Headache), ASTHENIA (Weakness), PAIN (Ache), PAIN IN EXTREMITY (Pain in arm), ERYTHEMA (Redness), PERIPHERAL SWELLING (Swelling arm), DIZZINESS (Dizziness), CHILLS (Chills) and THROAT TIGHTNESS (Throat tightness) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2020, SARS-CoV-2 antibody test: positive (Positive) Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No relevant concomitant medications were reported.

Other Meds:

Current Illness: Shellfish allergy

ID: 1551680
Sex: F
Age: 56
State: MA

Vax Date: 01/25/2021
Onset Date: 02/04/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Red rash around where the injection site; Red rash around where the injection site; A little painful; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Red rash around where the injection site), VACCINATION SITE ERYTHEMA (Red rash around where the injection site) and VACCINATION SITE PAIN (A little painful) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. Concurrent medical conditions included Allergy (The patient takes nasal spray for allergy). Concomitant products included GABAPENTIN, LEVOTHYROXINE SODIUM (SYNTHROID), VITAMIN D3 and KALLIDINOGENASE (SOMAX) for an unknown indication. On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE RASH (Red rash around where the injection site), VACCINATION SITE ERYTHEMA (Red rash around where the injection site) and VACCINATION SITE PAIN (A little painful). At the time of the report, VACCINATION SITE RASH (Red rash around where the injection site), VACCINATION SITE ERYTHEMA (Red rash around where the injection site) and VACCINATION SITE PAIN (A little painful) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The concomitant medication also included antidepressants, nasal spray for allergy. Treatment medications were not provided. This case was linked to MOD-2021-082190 (E2B Linked Report).; Sender's Comments: MOD-2021-082190:Same patient (2nd dose)

Other Meds: GABAPENTIN; SYNTHROID; VITAMIN D3; SOMAX

Current Illness: Allergy (The patient takes nasal spray for allergy)

ID: 1551681
Sex: F
Age: 85
State: MD

Vax Date: 02/04/2021
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Redness; Wheals; This spontaneous case was reported by a consumer and describes the occurrence of in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1551682
Sex: F
Age: 72
State: AZ

Vax Date: 02/12/2021
Onset Date: 02/13/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: redness extended down arm and around vaccination site; red itchy swollen endurated left arm; Injection site became hot to the touch; Injection site red/red itchy swollen endurated left arm; Injection site itchy/red itchy swollen endurated left arm; Injection site little swollen/red itchy swollen endurated left arm; covid arm; Arm was sore; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Arm was sore), VACCINATION SITE WARMTH (Injection site became hot to the touch), VACCINATION SITE ERYTHEMA (Injection site red/red itchy swollen endurated left arm), VACCINATION SITE PRURITUS (Injection site itchy/red itchy swollen endurated left arm) and VACCINATION SITE SWELLING (Injection site little swollen/red itchy swollen endurated left arm) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Drug allergy (Iodine Epinephrine), Hypertension, Acid reflux (oesophageal) and Congenital adrenal hyperplasia. Concomitant products included SIMVASTATIN (ZOCOR), SPIRONOLACTONE, OMEPRAZOLE (PROTONIX [OMEPRAZOLE]), MULTIVITAMINS [VITAMINS NOS], PROBIOTICS NOS, GLUTEN, ASCORBIC ACID, BIOTIN, COPPER, RETINOL, ZINC (HAIR SKIN NAILS), TURMERIC [CURCUMA LONGA RHIZOME], TOCOPHEROL (VITAMIN E [TOCOPHEROL]) and MAGNESIUM for an unknown indication. On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm was sore). On 22-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Injection site became hot to the touch), VACCINATION SITE ERYTHEMA (Injection site red/red itchy swollen endurated left arm), VACCINATION SITE PRURITUS (Injection site itchy/red itchy swollen endurated left arm), VACCINATION SITE SWELLING (Injection site little swollen/red itchy swollen endurated left arm) and ILL-DEFINED DISORDER (covid arm). On an unknown date, the patient experienced ERYTHEMA (redness extended down arm and around vaccination site) and VACCINATION SITE INDURATION (red itchy swollen endurated left arm). On 25-Feb-2021, ILL-DEFINED DISORDER (covid arm) had resolved. At the time of the report, PAIN IN EXTREMITY (Arm was sore), VACCINATION SITE WARMTH (Injection site became hot to the touch), VACCINATION SITE ERYTHEMA (Injection site red/red itchy swollen endurated left arm), VACCINATION SITE PRURITUS (Injection site itchy/red itchy swollen endurated left arm), VACCINATION SITE SWELLING (Injection site little swollen/red itchy swollen endurated left arm), ERYTHEMA (redness extended down arm and around vaccination site) and VACCINATION SITE INDURATION (red itchy swollen endurated left arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment medication information was provided. This case was linked to MOD-2021-108760 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Follow-up received on 30-APR-2021. The reporter provided the Historical condition details. Adverse Events updated.

Other Meds: ZOCOR; SPIRONOLACTONE; PROTONIX [OMEPRAZOLE]; MULTIVITAMINS [VITAMINS NOS]; PROBIOTICS NOS; GLUTEN; HAIR SKIN NAILS; TURMERIC [CURCUMA LONGA RHIZOME]; VITAMIN E [TOCOPHEROL]; MAGNESIUM

Current Illness: Acid reflux (oesophageal); Congenital adrenal hyperplasia; Hypertension

ID: 1551683
Sex: F
Age: 85
State: CA

Vax Date: 01/18/2021
Onset Date: 01/28/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: generalized pink discoloration near the injection site; covid arm; lump near the injection site; red patch on the injection upper arm; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE DISCOLOURATION (generalized pink discoloration near the injection site), TYPE IV HYPERSENSITIVITY REACTION (covid arm), INJECTION SITE SWELLING (lump near the injection site) and INJECTION SITE ERYTHEMA (red patch on the injection upper arm) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (NO historical condition reported.). On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 28-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (red patch on the injection upper arm). On 31-Jan-2021, the patient experienced INJECTION SITE DISCOLOURATION (generalized pink discoloration near the injection site), TYPE IV HYPERSENSITIVITY REACTION (covid arm) and INJECTION SITE SWELLING (lump near the injection site). At the time of the report, INJECTION SITE DISCOLOURATION (generalized pink discoloration near the injection site), TYPE IV HYPERSENSITIVITY REACTION (covid arm), INJECTION SITE SWELLING (lump near the injection site) and INJECTION SITE ERYTHEMA (red patch on the injection upper arm) outcome was unknown. Related Treatment details included Patient used Ice to treat the delayed injection site reaction. No relevant concomitant medications were reported For mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route), the reporter did not provide any causality assessments. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) was not applicable

Other Meds:

Current Illness:

ID: 1551684
Sex: M
Age:
State: TX

Vax Date: 02/12/2021
Onset Date: 02/21/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Hot at injection site; Red at injection site; Swollen at injection site; Itchy at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot at injection site), VACCINATION SITE ERYTHEMA (Red at injection site), VACCINATION SITE SWELLING (Swollen at injection site) and VACCINATION SITE PRURITUS (Itchy at injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concomitant products included FISH OIL, TURMERIC [CURCUMA LONGA RHIZOME], CUCURBITA PEPO SEED OIL, LYCOPENE, OENOTHERA BIENNIS OIL, SELENIUM, SERENOA REPENS, ZINC (SAW PALMETTO COMPLETE), CALCIUM, COLECALCIFEROL (VITAMIN D 3) and METHYLSULFONYLMETHANE (MSM COMPLETE) for an unknown indication. On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Hot at injection site), VACCINATION SITE ERYTHEMA (Red at injection site), VACCINATION SITE SWELLING (Swollen at injection site) and VACCINATION SITE PRURITUS (Itchy at injection site). At the time of the report, VACCINATION SITE WARMTH (Hot at injection site), VACCINATION SITE ERYTHEMA (Red at injection site), VACCINATION SITE SWELLING (Swollen at injection site) and VACCINATION SITE PRURITUS (Itchy at injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: FISH OIL; TURMERIC [CURCUMA LONGA RHIZOME]; SAW PALMETTO COMPLETE; CALCIUM; VITAMIN D 3; MSM COMPLETE

Current Illness:

ID: 1551685
Sex: F
Age:
State:

Vax Date: 01/20/2021
Onset Date: 01/01/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Vomiting; Body ache; Fever; Chills; Nausea; Headache; Joint pain; This spontaneous case was reported by a nurse and describes the occurrence of VOMITING (Vomiting), MYALGIA (Body ache), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 20-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced VOMITING (Vomiting), MYALGIA (Body ache), PYREXIA (Fever), CHILLS (Chills), NAUSEA (Nausea), HEADACHE (Headache) and ARTHRALGIA (Joint pain). At the time of the report, VOMITING (Vomiting), MYALGIA (Body ache), NAUSEA (Nausea), HEADACHE (Headache) and ARTHRALGIA (Joint pain) outcome was unknown and PYREXIA (Fever) and CHILLS (Chills) had not resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. The patient is a registered nurse who was reporting a "severe reaction to second dose". Concomitant product use was not provided. Approximately 8 hours after the second dose, the patient experienced the above mentioned events. The patient stated "I thought I was going to die." On unspecified dates, she tested negative numerous times for COVID-19, including a negative antibody. At the time of the report, 48 hours after the vaccine, the patient still had a low grade fever and chills but said "am feeling better." Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1551686
Sex: F
Age: 70
State: VA

Vax Date: 02/11/2021
Onset Date: 02/21/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Had redness on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Had redness on the injection site) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. No Medical History information was reported. On 11-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Had redness on the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (Had redness on the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1551687
Sex: F
Age: 56
State: NY

Vax Date: 02/10/2021
Onset Date: 02/10/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: itching at the injection site; redness at the injection site; swelling at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itching at the injection site), VACCINATION SITE ERYTHEMA (redness at the injection site) and VACCINATION SITE SWELLING (swelling at the injection site) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (itching at the injection site), VACCINATION SITE ERYTHEMA (redness at the injection site) and VACCINATION SITE SWELLING (swelling at the injection site). The patient was treated with CORTISONE ACETATE at an unspecified dose and frequency and ANTIBIOTICS at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PRURITUS (itching at the injection site), VACCINATION SITE ERYTHEMA (redness at the injection site) and VACCINATION SITE SWELLING (swelling at the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.

Other Meds:

Current Illness:

ID: 1551688
Sex: F
Age: 74
State: CA

Vax Date: 01/19/2021
Onset Date: 01/19/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: She had a little reaction, little redness, and soreness and warmth, tenderness, (2 days) red rash 7 cm X 13 cm occurring at the injection site.; Red rash 7 cm X 13 cm occurring at the injection site; Tenderness at the injection site; Redness at the injection site/red at the injection site; Soreness at the at the injection site; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (She had a little reaction, little redness, and soreness and warmth, tenderness, (2 days) red rash 7 cm X 13 cm occurring at the injection site.), VACCINATION SITE ERYTHEMA (Redness at the injection site/red at the injection site), VACCINATION SITE PAIN (Soreness at the at the injection site), VACCINATION SITE RASH (Red rash 7 cm X 13 cm occurring at the injection site) and VACCINATION SITE PAIN (Tenderness at the injection site) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for COVID-19 vaccination. Concurrent medical conditions included Allergy to insect sting (Sensitive to mosquito and flea bites). On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness at the injection site/red at the injection site) and VACCINATION SITE PAIN (Soreness at the at the injection site). On 28-Jan-2021, the patient experienced VACCINATION SITE WARMTH (She had a little reaction, little redness, and soreness and warmth, tenderness, (2 days) red rash 7 cm X 13 cm occurring at the injection site.), VACCINATION SITE RASH (Red rash 7 cm X 13 cm occurring at the injection site) and VACCINATION SITE PAIN (Tenderness at the injection site). On 30-Jan-2021, VACCINATION SITE PAIN (Soreness at the at the injection site) and VACCINATION SITE PAIN (Tenderness at the injection site) had resolved. At the time of the report, VACCINATION SITE WARMTH (She had a little reaction, little redness, and soreness and warmth, tenderness, (2 days) red rash 7 cm X 13 cm occurring at the injection site.) had not resolved and VACCINATION SITE ERYTHEMA (Redness at the injection site/red at the injection site) and VACCINATION SITE RASH (Red rash 7 cm X 13 cm occurring at the injection site) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. The patient had a little reaction, little redness and soreness went away after a few days and 9 days later (28-Jan-2021) she had COVID arm: warmth, tenderness, (2 days) red rash 7 cm X 13 cm occurring at the injection site which had faded to a pink at the time of this report. Treatment information were not provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness: Allergy to insect sting (Sensitive to mosquito and flea bites)

ID: 1551689
Sex: M
Age: 69
State: WI

Vax Date: 02/18/2021
Onset Date: 02/18/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Severe headache; Muscle pain; Fatigue; Stiffness in shoulder; Severe chills/was shaking for 4 hours; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Stiffness in shoulder), CHILLS (Severe chills/was shaking for 4 hours), HEADACHE (Severe headache), MYALGIA (Muscle pain) and FATIGUE (Fatigue) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The patient's past medical history included COVID-19 in November 2020. Concomitant products included RIVAROXABAN (XARELTO) and ATORVASTATIN for an unknown indication. On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Stiffness in shoulder) and CHILLS (Severe chills/was shaking for 4 hours). On 19-Feb-2021, the patient experienced HEADACHE (Severe headache), MYALGIA (Muscle pain) and FATIGUE (Fatigue). At the time of the report, MUSCULOSKELETAL STIFFNESS (Stiffness in shoulder), CHILLS (Severe chills/was shaking for 4 hours), HEADACHE (Severe headache), MYALGIA (Muscle pain) and FATIGUE (Fatigue) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Treatment medications were not provided by reporter.

Other Meds: XARELTO; ATORVASTATIN

Current Illness:

ID: 1551690
Sex: F
Age: 78
State: TX

Vax Date: 01/27/2021
Onset Date: 02/16/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Shingles; A spontaneous report was received from a consumer concerning a 79-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events shingles. The patient's medical history was not provided. No relevant concomitant medications were reported. On 27 Jan 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 025L20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection. On 16 Feb 2021, the patient experienced the event(s) shingles. Treatment details included valacyclovir. Action taken with mRNA-1273 in response to the events was not reported. The outcome of event(s), shingles was unknown.

Other Meds:

Current Illness:

ID: 1551691
Sex: F
Age:
State: LA

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Red spot; it itched alot; This spontaneous case was reported by a pharmacist and describes the occurrence of RASH MACULAR (Red spot) and PRURITUS (it itched alot) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. No Medical History information was reported. On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced RASH MACULAR (Red spot) and PRURITUS (it itched alot). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 07-Jan-2021 for Vaccination site reaction, at an unspecified dose and frequency. At the time of the report, RASH MACULAR (Red spot) and PRURITUS (it itched alot) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medications were not provided by reporter.

Other Meds:

Current Illness:

ID: 1551692
Sex: F
Age: 77
State: NJ

Vax Date: 02/03/2021
Onset Date: 02/05/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: left arm hurts; peed with a strange smell and left some pink in the toilet; patient peed with a strange smell; This spontaneous case was reported by a patient family member or friend and describes the occurrence of PAIN IN EXTREMITY (left arm hurts), CHROMATURIA (peed with a strange smell and left some pink in the toilet) and URINE ODOUR ABNORMAL (patient peed with a strange smell) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. Concurrent medical conditions included Hypertension, Cholesterol and Hemorrhoids. On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced CHROMATURIA (peed with a strange smell and left some pink in the toilet) and URINE ODOUR ABNORMAL (patient peed with a strange smell). On an unknown date, the patient experienced PAIN IN EXTREMITY (left arm hurts). At the time of the report, PAIN IN EXTREMITY (left arm hurts), CHROMATURIA (peed with a strange smell and left some pink in the toilet) and URINE ODOUR ABNORMAL (patient peed with a strange smell) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. concomitant medications included: Blood pressure, cholesterol medication and unspecified medications. No treatment information was provided.

Other Meds:

Current Illness: Cholesterol; Hemorrhoids; Hypertension

ID: 1551693
Sex: F
Age: 83
State: MT

Vax Date: 02/19/2021
Onset Date: 02/19/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Arm was red from shoulder to elbow; Weakness; Lost her appetite; Pajamas were wet like she had a fever; Wart in between shoulder and arm; Dizziness; Arm was itching underneath; Joint pain; Little drowsy; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Little drowsy), ERYTHEMA (Arm was red from shoulder to elbow), ASTHENIA (Weakness), DECREASED APPETITE (Lost her appetite) and HYPERHIDROSIS (Pajamas were wet like she had a fever) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced SOMNOLENCE (Little drowsy), PRURITUS (Arm was itching underneath) and ARTHRALGIA (Joint pain). On 20-Feb-2021, the patient experienced ERYTHEMA (Arm was red from shoulder to elbow), ASTHENIA (Weakness), DECREASED APPETITE (Lost her appetite), HYPERHIDROSIS (Pajamas were wet like she had a fever), SKIN PAPILLOMA (Wart in between shoulder and arm) and DIZZINESS (Dizziness). On 19-Feb-2021, SOMNOLENCE (Little drowsy) had resolved. On 20-Feb-2021, HYPERHIDROSIS (Pajamas were wet like she had a fever) had resolved. On 21-Feb-2021, DECREASED APPETITE (Lost her appetite) had resolved. At the time of the report, ERYTHEMA (Arm was red from shoulder to elbow), ASTHENIA (Weakness), SKIN PAPILLOMA (Wart in between shoulder and arm), DIZZINESS (Dizziness), PRURITUS (Arm was itching underneath) and ARTHRALGIA (Joint pain) outcome was unknown. Treatment and concomitant medications were not provided by reporter.

Other Meds:

Current Illness:

ID: 1551694
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Slightly sore arm 24 hours after getting the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Slightly sore arm 24 hours after getting the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (Slightly sore arm 24 hours after getting the vaccine). At the time of the report, VACCINATION SITE PAIN (Slightly sore arm 24 hours after getting the vaccine) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The concomitant medications and treatment details were not provided. Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: Follow-up information received on 15-Apr-2021 included email ID, onset latency of the event slightly sore arm 24 hours after getting the vaccine.

Other Meds:

Current Illness:

ID: 1551695
Sex: F
Age:
State: NY

Vax Date: 02/12/2021
Onset Date: 02/12/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: red bump; headache; Red; little bruise; swelled; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (little bruise), VACCINATION SITE MASS (red bump), HEADACHE (headache), VACCINATION SITE SWELLING (swelled) and VACCINATION SITE ERYTHEMA (Red) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. U06M20A) for COVID-19 vaccination. No Medical History information was reported. On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced VACCINATION SITE BRUISING (little bruise) and VACCINATION SITE SWELLING (swelled). On 21-Feb-2021, the patient experienced VACCINATION SITE MASS (red bump), HEADACHE (headache) and VACCINATION SITE ERYTHEMA (Red). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form and BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, PRAMOCAINE HYDROCHLORIDE (NEOSPORIN + BURN RELIEF) at a dose of 1 dosage form. At the time of the report, VACCINATION SITE BRUISING (little bruise), VACCINATION SITE MASS (red bump), HEADACHE (headache), VACCINATION SITE SWELLING (swelled) and VACCINATION SITE ERYTHEMA (Red) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medications were not provided by reporter.

Other Meds:

Current Illness:

ID: 1551696
Sex: F
Age: 79
State: FL

Vax Date: 02/09/2021
Onset Date: 02/10/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Muscle Spasms; Really exhausted; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Really exhausted) and MUSCLE SPASMS (Muscle Spasms) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. No Medical History information was reported. On 09-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced FATIGUE (Really exhausted). On 20-Feb-2021, the patient experienced MUSCLE SPASMS (Muscle Spasms). On 20-Feb-2021, MUSCLE SPASMS (Muscle Spasms) had resolved. At the time of the report, FATIGUE (Really exhausted) outcome was unknown. Treatment and concomitant medications were not provided by reporter. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1551697
Sex: F
Age: 70
State:

Vax Date: 02/15/2021
Onset Date: 02/15/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Hives all over the body; Itchy all over the body; Stayed in bed for 3 days; Fever; Headache; Vomits; Does not want to eat, does not have appetite; Is not able to sleep; Intense pain in the arm, from the thumb to the ears; Intense cold; Felt very dizzy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Intense pain in the arm, from the thumb to the ears), FEELING COLD (Intense cold), DIZZINESS (Felt very dizzy), URTICARIA (Hives all over the body) and DECREASED APPETITE (Does not want to eat, does not have appetite) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History was provided by the reporter. Concurrent medical conditions included Asthma, Allergy to animal (Allergic to cats, dogs), Allergy (Allergy to pines) and Dust allergy. Concomitant products included FLUTICASONE PROPIONATE (FLOVENT) for Asthma, IBANDRONATE SODIUM (BONIVA), VITAMINS NOS, MAGNESIUM, POTASSIUM, FOLIC ACID and CALCIUM CITRATE, COLECALCIFEROL (CITRACAL + D3) for an unknown indication. On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced PAIN IN EXTREMITY (Intense pain in the arm, from the thumb to the ears), FEELING COLD (Intense cold), DIZZINESS (Felt very dizzy), DECREASED APPETITE (Does not want to eat, does not have appetite), INSOMNIA (Is not able to sleep), ILLNESS (Stayed in bed for 3 days), PYREXIA (Fever), HEADACHE (Headache) and VOMITING (Vomits). On 16-Feb-2021, the patient experienced URTICARIA (Hives all over the body) and PRURITUS (Itchy all over the body). The patient was treated with IBUPROFEN (oral) on 15-Feb-2021 for Hives, at a dose of 1 dosage form; CLARITHROMYCIN (CLARITIN [CLARITHROMYCIN]) (oral) on 15-Feb-2021 for Hives, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) on 15-Feb-2021 for Hives, at an unspecified dose and frequency. On 15-Feb-2021, VOMITING (Vomits) had resolved. On 17-Feb-2021, PAIN IN EXTREMITY (Intense pain in the arm, from the thumb to the ears), FEELING COLD (Intense cold), DIZZINESS (Felt very dizzy), URTICARIA (Hives all over the body), ILLNESS (Stayed in bed for 3 days), PYREXIA (Fever) and HEADACHE (Headache) had resolved. At the time of the report, DECREASED APPETITE (Does not want to eat, does not have appetite), INSOMNIA (Is not able to sleep) and PRURITUS (Itchy all over the body) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Feb-2021, Body temperature: 102 (High) Patient had fever of 102 F. On 16-Feb-2021, Body temperature: 101 (High) Patient had fever of 101?F.. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021

Other Meds: BONIVA; VITAMINS NOS; MAGNESIUM; POTASSIUM; FOLIC ACID; CITRACAL + D3; FLOVENT

Current Illness: Allergy (Allergy to pines); Allergy to animal (Allergic to cats, dogs); Asthma; Dust allergy

ID: 1551698
Sex: F
Age: 90
State: FL

Vax Date: 02/09/2021
Onset Date: 02/10/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: loss of appetite; arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm pain) and DECREASED APPETITE (loss of appetite) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. Concurrent medical conditions included Diabetes. Concomitant products included CARBOHYDRATES NOS, CHOLESTEROL, FATS NOS, MINERALS NOS, POTASSIUM, PROTEIN, SODIUM, VITAMINS NOS (GLUCERNA ADVANCE) for Diabetes mellitus. On 09-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm pain). On 16-Feb-2021, the patient experienced DECREASED APPETITE (loss of appetite). On 10-Feb-2021, PAIN IN EXTREMITY (arm pain) had resolved. At the time of the report, DECREASED APPETITE (loss of appetite) outcome was unknown. Treatment medications were not provided by reporter.

Other Meds: GLUCERNA ADVANCE

Current Illness: Diabetes

ID: 1551699
Sex: M
Age:
State: NY

Vax Date: 01/16/2021
Onset Date: 02/16/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: vertigo; dizziness; nausea; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (vertigo), DIZZINESS (dizziness) and NAUSEA (nausea) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 026L20A) for COVID-19 vaccination. No Medical History information was reported. On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Feb-2021, the patient experienced VERTIGO (vertigo), DIZZINESS (dizziness) and NAUSEA (nausea). On 17-Feb-2021, VERTIGO (vertigo), DIZZINESS (dizziness) and NAUSEA (nausea) had resolved. Treatment and concomitant medications were not provided by reporter.

Other Meds:

Current Illness:

ID: 1551700
Sex: F
Age: 72
State: MI

Vax Date: 02/05/2021
Onset Date: 02/05/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: started itching at the injection site and around it; soreness at the injection site; swollen; redness; tenderness,if she lay down her arm it is tender; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness at the injection site), VACCINATION SITE SWELLING (swollen), VACCINATION SITE ERYTHEMA (redness), VACCINATION SITE PAIN (tenderness,if she lay down her arm it is tender) and VACCINATION SITE PRURITUS (started itching at the injection site and around it) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The patient's past medical history included Osteoporosis, Hypertension, Renal disease, Vitamin D deficiency, Chronic back pain, Lumbosacral (joint) (ligament) sprain and Constipation. Concomitant products included AMLODIPINE for Hypertension, METOPROLOL and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication. On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced VACCINATION SITE PAIN (soreness at the injection site), VACCINATION SITE SWELLING (swollen), VACCINATION SITE ERYTHEMA (redness) and VACCINATION SITE PAIN (tenderness,if she lay down her arm it is tender). On an unknown date, the patient experienced VACCINATION SITE PRURITUS (started itching at the injection site and around it). At the time of the report, VACCINATION SITE PAIN (soreness at the injection site), VACCINATION SITE SWELLING (swollen), VACCINATION SITE ERYTHEMA (redness), VACCINATION SITE PAIN (tenderness,if she lay down her arm it is tender) and VACCINATION SITE PRURITUS (started itching at the injection site and around it) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Treatment medication included white alcohol.

Other Meds: METOPROLOL; VITAMIN D 2000; AMLODIPINE

Current Illness:

ID: 1551701
Sex: F
Age: 89
State: TX

Vax Date: 02/11/2021
Onset Date: 02/11/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swelling; a little warm beneath; redness; The arm is a little sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swelling), VACCINATION SITE ERYTHEMA (redness), VACCINATION SITE WARMTH (a little warm beneath) and PAIN IN EXTREMITY (The arm is a little sore) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The patient's past medical history included Stroke in 2003, Colitis, Osteoporosis, Cholesterol and Heart disease, unspecified. On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced PAIN IN EXTREMITY (The arm is a little sore). On 12-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness). On an unknown date, the patient experienced VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE WARMTH (a little warm beneath). At the time of the report, VACCINATION SITE SWELLING (Swelling), VACCINATION SITE ERYTHEMA (redness), VACCINATION SITE WARMTH (a little warm beneath) and PAIN IN EXTREMITY (The arm is a little sore) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Treatment medications were not provided by reporter. Concomitant medications reported were colitis medications,osteoporosis medications,cholesterol med,and heart medications.

Other Meds:

Current Illness:

ID: 1551702
Sex: F
Age: 65
State: DC

Vax Date: 01/19/2021
Onset Date: 01/19/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: mild arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020L20A) for COVID-19 vaccination. no medical history was provided by the reporter. Concomitant products included ATORVASTATIN for Cholesterol, LISINOPRIL for Hypertension, LEVOTHYROXINE for Parathyroid tumour. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged. treatment medication: tylenol Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: Caller returning call from Safety, concomitant medication was updated

Other Meds: LEVOTHYROXINE; LISINOPRIL; ATORVASTATIN

Current Illness:

ID: 1551703
Sex: M
Age:
State: FL

Vax Date:
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sore arm; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and CHILLS (Chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm) and CHILLS (Chills). At the time of the report, PAIN IN EXTREMITY (Sore arm) and CHILLS (Chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product use was not provided by the reporter. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1551704
Sex: F
Age: 90
State: CA

Vax Date: 02/10/2021
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: rash at the site of injection; her arm started to itch; excessive sweat across stomach area; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE RASH (rash at the site of injection), PRURITUS (her arm started to itch) and HYPERHIDROSIS (excessive sweat across stomach area) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. No Medical History information was reported. On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE RASH (rash at the site of injection), PRURITUS (her arm started to itch) and HYPERHIDROSIS (excessive sweat across stomach area). At the time of the report, INJECTION SITE RASH (rash at the site of injection), PRURITUS (her arm started to itch) and HYPERHIDROSIS (excessive sweat across stomach area) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Treatment and concomitant medications were not provided by reporter.

Other Meds:

Current Illness:

ID: 1551705
Sex: F
Age:
State: PA

Vax Date: 02/12/2021
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: postnasal drip; 2 ear aches; This spontaneous case was reported by a consumer and describes the occurrence of UPPER-AIRWAY COUGH SYNDROME (postnasal drip) and EAR PAIN (2 ear aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced UPPER-AIRWAY COUGH SYNDROME (postnasal drip) and EAR PAIN (2 ear aches). The patient was treated with PREDNISOLONE at an unspecified dose and frequency. At the time of the report, UPPER-AIRWAY COUGH SYNDROME (postnasal drip) and EAR PAIN (2 ear aches) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided by reporter.

Other Meds:

Current Illness:

ID: 1551706
Sex: F
Age:
State: WA

Vax Date: 01/16/2021
Onset Date: 01/17/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sore arm; injection site swelling, red about the size of a tennis ball- HCP dx cellulitis; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (sore arm) and VACCINATION SITE CELLULITIS (injection site swelling, red about the size of a tennis ball- HCP dx cellulitis) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Cellulitis (the patient had symptoms like cellulitis.) on 17-Jan-2021. Concomitant products included ROSUVASTATIN, METOPROLOL and LEVOTHYROXINE for an unknown indication. On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and VACCINATION SITE CELLULITIS (injection site swelling, red about the size of a tennis ball- HCP dx cellulitis). The patient was treated with NEOMYCIN SULFATE, POLYMYXIN B SULFATE (ANTIBIOTIC [NEOMYCIN SULFATE;POLYMYXIN B SULFATE]) (oral) on 17-Jan-2021 for Cellulitis, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm) and VACCINATION SITE CELLULITIS (injection site swelling, red about the size of a tennis ball- HCP dx cellulitis) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.

Other Meds: ROSUVASTATIN; METOPROLOL; LEVOTHYROXINE

Current Illness:

ID: 1551707
Sex: F
Age: 80
State: MD

Vax Date: 01/25/2021
Onset Date: 02/19/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: slipped and broke her ankle; This spontaneous case was reported by a consumer and describes the occurrence of JOINT INJURY (slipped and broke her ankle) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced JOINT INJURY (slipped and broke her ankle). At the time of the report, JOINT INJURY (slipped and broke her ankle) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications provided. No treatment information provided. Reporter did not allow further contact Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Follow up received on 25-May-202 contains no significant information.

Other Meds:

Current Illness:

ID: 1551708
Sex: F
Age: 46
State: NJ

Vax Date: 01/19/2021
Onset Date: 01/19/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Injection site is red; injection site itching; Headache; sore left arm; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (sore left arm), VACCINATION SITE PRURITUS (injection site itching), HEADACHE (Headache) and VACCINATION SITE ERYTHEMA (Injection site is red) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. No Medical History information was reported. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore left arm) and HEADACHE (Headache). On 26-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (injection site itching). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Injection site is red). On 19-Jan-2021, HEADACHE (Headache) had resolved. On 20-Jan-2021, PAIN IN EXTREMITY (sore left arm) had resolved. At the time of the report, VACCINATION SITE PRURITUS (injection site itching) and VACCINATION SITE ERYTHEMA (Injection site is red) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. .

Other Meds:

Current Illness:

ID: 1551709
Sex: F
Age: 57
State: FL

Vax Date: 02/01/2021
Onset Date: 02/04/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Minor itchiness by the upper body; Pain going down from the side on my neck; Warm by the rash; Rash on the chest; Soreness at injection; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Minor itchiness by the upper body), NECK PAIN (Pain going down from the side on my neck), FEELING HOT (Warm by the rash), RASH (Rash on the chest) and VACCINATION SITE PAIN (Soreness at injection) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination. no specified medical history was reported. Concomitant products included LISINOPRIL and VITAMINS NOS for an unknown indication. On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced PRURITUS (Minor itchiness by the upper body), NECK PAIN (Pain going down from the side on my neck), FEELING HOT (Warm by the rash), RASH (Rash on the chest) and VACCINATION SITE PAIN (Soreness at injection). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency. At the time of the report, PRURITUS (Minor itchiness by the upper body), NECK PAIN (Pain going down from the side on my neck), FEELING HOT (Warm by the rash), RASH (Rash on the chest) and VACCINATION SITE PAIN (Soreness at injection) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: LISINOPRIL; VITAMINS NOS

Current Illness:

ID: 1551710
Sex: M
Age:
State: CA

Vax Date: 02/02/2021
Onset Date: 02/02/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Irritable; Severe Headache; Extreme Fatigue; Muscle Aches; This spontaneous case was reported by a consumer and describes the occurrence of IRRITABILITY (Irritable), HEADACHE (Severe Headache), FATIGUE (Extreme Fatigue) and MYALGIA (Muscle Aches) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. Concomitant products included DOXYCYCLINE for Skin damage. On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced IRRITABILITY (Irritable), HEADACHE (Severe Headache), FATIGUE (Extreme Fatigue) and MYALGIA (Muscle Aches). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, IRRITABILITY (Irritable), HEADACHE (Severe Headache), FATIGUE (Extreme Fatigue) and MYALGIA (Muscle Aches) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.

Other Meds: DOXYCYCLINE

Current Illness:

ID: 1551711
Sex: F
Age: 76
State: FL

Vax Date: 02/13/2021
Onset Date: 02/18/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Vertigo; Itchiness on arm; Rash from elbow the elbow to the shoulder (injection arm); This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo), PRURITUS (Itchiness on arm) and RASH (Rash from elbow the elbow to the shoulder (injection arm)) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The patient's past medical history included COVID-19 from November 2020 to December 2020. Concomitant products included ROSUVASTATIN for Cholesterol, CLOPIDOGREL, METOPROLOL SUCCINATE (METOPROLOL [METOPROLOL SUCCINATE]), LISINOPRIL, ALLOPURINOL, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and COPD Inhaler for an unknown indication. On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced PRURITUS (Itchiness on arm) and RASH (Rash from elbow the elbow to the shoulder (injection arm)). On 21-Feb-2021, the patient experienced VERTIGO (Vertigo). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency and HYDROCORTISONE ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, VERTIGO (Vertigo), PRURITUS (Itchiness on arm) and RASH (Rash from elbow the elbow to the shoulder (injection arm)) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2020, SARS-CoV-2 test: positive Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds: CLOPIDOGREL; METOPROLOL [METOPROLOL SUCCINATE]; LISINOPRIL; ALLOPURINOL; ROSUVASTATIN; VITAMIN D 2000; COPD Inhaler

Current Illness:

ID: 1551712
Sex: F
Age:
State: NJ

Vax Date: 02/02/2021
Onset Date: 02/02/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Knot in cubital fossa; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (Knot in cubital fossa) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced JOINT SWELLING (Knot in cubital fossa). At the time of the report, JOINT SWELLING (Knot in cubital fossa) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment was received by the patient. No concomitant medication was received by the patient. Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Follow up was received on 06-JUL-2021: contains non significant information.

Other Meds:

Current Illness:

ID: 1551713
Sex: M
Age: 56
State: NY

Vax Date: 01/05/2021
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Red, itchy,slightly tinted rash on his collar bone and the top of his sternum; Tingling sensation; Red, itchy,slightly tinted rash on his collar bone and the top of his sternum; Slightly tinted rash on his collar bone and the top of his sternum; The rash increasingly spread to his stomach with a lighter rash in places around his under arm but not in his arm pit, down his arm, and down the side of his torso; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Red, itchy,slightly tinted rash on his collar bone and the top of his sternum), PARAESTHESIA (Tingling sensation), ERYTHEMA (Red, itchy,slightly tinted rash on his collar bone and the top of his sternum), RASH (Slightly tinted rash on his collar bone and the top of his sternum) and RASH (The rash increasingly spread to his stomach with a lighter rash in places around his under arm but not in his arm pit, down his arm, and down the side of his torso) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 028L20A) for COVID-19 vaccination. No Medical History information was reported. On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRURITUS (Red, itchy,slightly tinted rash on his collar bone and the top of his sternum), PARAESTHESIA (Tingling sensation), ERYTHEMA (Red, itchy,slightly tinted rash on his collar bone and the top of his sternum), RASH (Slightly tinted rash on his collar bone and the top of his sternum) and RASH (The rash increasingly spread to his stomach with a lighter rash in places around his under arm but not in his arm pit, down his arm, and down the side of his torso). The patient was treated with HYDROCORTISONE ongoing since an unknown date for Rash, at an unspecified dose and frequency and LORATADINE (CLARITIN [LORATADINE]) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, PRURITUS (Red, itchy,slightly tinted rash on his collar bone and the top of his sternum), PARAESTHESIA (Tingling sensation), ERYTHEMA (Red, itchy,slightly tinted rash on his collar bone and the top of his sternum), RASH (Slightly tinted rash on his collar bone and the top of his sternum) and RASH (The rash increasingly spread to his stomach with a lighter rash in places around his under arm but not in his arm pit, down his arm, and down the side of his torso) outcome was unknown. The concomitant medications were not provided. Treatment medication also included antifungal cream.

Other Meds:

Current Illness:

ID: 1551714
Sex: F
Age:
State: PA

Vax Date:
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: arm swelled, big patch; broke out with all body rash; a lot of swelling at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm swelled, big patch), RASH (broke out with all body rash) and VACCINATION SITE SWELLING (a lot of swelling at the injection site) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (arm swelled, big patch), RASH (broke out with all body rash) and VACCINATION SITE SWELLING (a lot of swelling at the injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (arm swelled, big patch), RASH (broke out with all body rash) and VACCINATION SITE SWELLING (a lot of swelling at the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds:

Current Illness:

ID: 1551715
Sex: F
Age: 73
State: PA

Vax Date: 01/29/2021
Onset Date: 01/29/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itching from head to toe; Tongue was very dry; A spontaneous report was received from a consumer concerning a 73-years-old patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events itching from head to toe, tongue was very dry. The patient's medical history was not provided. Concomitant medications reported were Blood pressure meds, Vitamin d 3, Baby aspirin, Calcium for drug use for unknown indication. On 29 Jan 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 012k20a) intramuscularly for prophylaxis of COVID-19 infection. On 29 Jan 2021, the patient experienced the event(s) itching from head to toe, tongue was very dry. Treatment details included Zyrtec. Action taken with mRNA-1273 in response to the events was not reported. The outcome of event(s), itching from head to toe, tongue was very dry was unknown.

Other Meds: Blood pressure meds; VITAMIN D 2000; BABY ASPIRIN; CALCIUM

Current Illness:

ID: 1551716
Sex: M
Age:
State: IL

Vax Date: 02/22/2021
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: body aches; chills; light headache; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (body aches), CHILLS (chills) and HEADACHE (light headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 22-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (body aches), CHILLS (chills) and HEADACHE (light headache). The patient was treated with IBUPROFEN at an unspecified dose and frequency and ACETAMINOPHEN ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, MYALGIA (body aches), CHILLS (chills) and HEADACHE (light headache) outcome was unknown. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1551717
Sex: F
Age:
State: PA

Vax Date:
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Red welt at injection site; Pain at injection site/Tenderness at injection site; Redness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Red welt at injection site), VACCINATION SITE PAIN (Pain at injection site/Tenderness at injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. no specified medical history was reported. Concomitant products included LISINOPRIL and PRAVASTATIN for an unknown indication. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (Red welt at injection site), VACCINATION SITE PAIN (Pain at injection site/Tenderness at injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site). The patient was treated with NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE SWELLING (Red welt at injection site), VACCINATION SITE PAIN (Pain at injection site/Tenderness at injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: LISINOPRIL; PRAVASTATIN

Current Illness:

ID: 1551718
Sex: F
Age: 59
State: MI

Vax Date: 01/23/2021
Onset Date: 01/24/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tingling on left side of the face; Weird thinking; Weird dreams; Heavy foot feeling; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PARAESTHESIA (Tingling on left side of the face), FEELING ABNORMAL (Weird thinking), ABNORMAL DREAMS (Weird dreams) and LIMB DISCOMFORT (Heavy foot feeling) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. Concurrent medical conditions included Anxiety. Concomitant products included CLONAZEPAM (KLONOPIN) for Anxiety, LEVOTHYROXINE SODIUM (SYNTHROID), VENLAFAXINE HYDROCHLORIDE (EFFEXOR), AMLODIPINE BESILATE (NORVASC), LOSARTAN and OMEPRAZOLE MAGNESIUM (PRILOSEC [OMEPRAZOLE MAGNESIUM]) for an unknown indication. On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Jan-2021, the patient experienced PARAESTHESIA (Tingling on left side of the face), FEELING ABNORMAL (Weird thinking), ABNORMAL DREAMS (Weird dreams) and LIMB DISCOMFORT (Heavy foot feeling). The patient was treated with PARACETAMOL (TYLENOL) for product used for unkown indication, at an unspecified dose and frequency. On 25-Jan-2021, PARAESTHESIA (Tingling on left side of the face), FEELING ABNORMAL (Weird thinking) and ABNORMAL DREAMS (Weird dreams) had resolved. At the time of the report, LIMB DISCOMFORT (Heavy foot feeling) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. This case was linked to MOD-2021-021655 (Patient Link).

Other Meds: SYNTHROID; EFFEXOR; NORVASC; LOSARTAN; PRILOSEC [OMEPRAZOLE MAGNESIUM]; KLONOPIN

Current Illness: Anxiety

ID: 1551719
Sex: M
Age:
State: IL

Vax Date:
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tingling at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PARAESTHESIA (tingling at injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PARAESTHESIA (tingling at injection site). At the time of the report, VACCINATION SITE PARAESTHESIA (tingling at injection site) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications and treatment medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: Follow-up received on 16-Apr-2021 included no new information.

Other Meds:

Current Illness:

ID: 1551720
Sex: F
Age: 74
State:

Vax Date: 01/28/2021
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: swelling in the right arm; rash in the right arm; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE SWELLING (swelling in the right arm) and VACCINATION SITE RASH (rash in the right arm) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013l20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (swelling in the right arm) and VACCINATION SITE RASH (rash in the right arm). At the time of the report, VACCINATION SITE SWELLING (swelling in the right arm) and VACCINATION SITE RASH (rash in the right arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment: The patient was given antihistamine and cream as treatment.

Other Meds:

Current Illness:

ID: 1551721
Sex: F
Age:
State: TX

Vax Date: 12/23/2020
Onset Date: 12/24/2020
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Covid19; This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 (Covid19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Dec-2020, the patient experienced COVID-19 (Covid19). On 14-Jan-2021, COVID-19 (Covid19) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.

Other Meds:

Current Illness:

ID: 1551722
Sex: F
Age: 75
State: NY

Vax Date: 02/16/2021
Onset Date: 02/16/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Concomitant products included PARACETAMOL (TYLENOL), TRAMADOL, ACETYLSALICYLIC ACID (BABY ASPIRIN), MULTIVITAMIN & MINERAL, ATORVASTATIN and METOPROLOL for an unknown indication. On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 16-Feb-2021, the patient experienced PAIN IN EXTREMITY (pain in my left arm). On an unknown date, the patient experienced MOBILITY DECREASED (trouble lifting my left arm/still have some limited use of my arm/still having complications with my arm.) and DISCOMFORT (No longer tolerate the pain and discomfort). The patient was treated with IBUPROFEN (ADVIL 12 HOUR) for Pain, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (pain in my left arm) had not resolved and MOBILITY DECREASED (trouble lifting my left arm/still have some limited use of my arm/still having complications with my arm.) and DISCOMFORT (No longer tolerate the pain and discomfort) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No medical history provided by the reporter. Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Event outcome updated.

Other Meds: TYLENOL; TRAMADOL; BABY ASPIRIN; MULTIVITAMIN & MINERAL; ATORVASTATIN; METOPROLOL

Current Illness:

Total 2021 VAERS Injuries: 704,237

Page last modified: 03 October 2021 5:28pm